1. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease by Fabrizio Tomai, Flavio Ribichini, Anna S. Ghini, Valeria Ferrero, Giuseppe Andò, Corrado Vassanelli, Francesco Romeo, Filippo Crea, and Luigi Chiariello EHJ Volume 26(20):2099-2105 September 29, 2005 © The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

2. Figure 1 Per cent changes from baseline of CBF in response to substance P infusion. Fabrizio Tomai et al. Eur Heart J 2005;26:2099-2105 © The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

3. Figure 2 Per cent changes from baseline of CBF in response to adenosine infusion. Fabrizio Tomai et al. Eur Heart J 2005;26:2099-2105 © The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

4. Figure 3 Relation between per cent changes from baseline of CBF in response to the peak dose of substance P and logarithmically transformed C-reactive protein levels (log-C-reactive protein). Fabrizio Tomai et al. Eur Heart J 2005;26:2099-2105 © The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

5. Figure 4 Relation between per cent changes from baseline of CBF in response to adenosine and logarithmically transformed C-reactive protein levels (log-C-reactive protein). Fabrizio Tomai et al. Eur Heart J 2005;26:2099-2105 © The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org